saman rahmanian
143 posts

saman rahmanian
@saman
Co-Founder and Chief Product Officer of @Ro, Co-Founder of @managedbyq, Partner at @prehype - I don't post on X; Hit me on LinkedIn
New York, USA Katılım Aralık 2008
208 Takip Edilen25.2K Takipçiler

BIG NEWS! 🚀🚀🚀
Today, we're announcing that we're working with @EliLillyandCo to expand access to Zepbound vials.
cnbc.com/2024/12/11/ro-…
Every day we fight to give our patients the easiest and most effective healthcare possible. Ro’s work with Lilly making Zepbound single-dose vials seamlessly available through @ro is a big step toward that goal.
Integrating Ro’s platform with LillyDirect means that we offer an end-to-end experience pairing access to Zepbound single-dose vials with everything patients need to achieve their health goals – from diagnosis to delivery of medication and ongoing care.
Ro has always believed in the ability of our direct-to-patient platform to transform healthcare for millions of patients, and it’s incredibly exciting to work with a leader like Lilly to expand access to their life-changing, FDA-approved medicines.
English

While we’ve built ro.OS over the past six years, now we’re excited to share more about this technology, how we built it, and how it’s helped millions of patients more easily and effectively achieve their health goals. ro.co/perspectives/o…
English

Awesome article on the far-reaching effects of GLP-1s across many industries by the one and only @ZReitano
Z Reitano@ZReitano
Food For Thought: The Potential Ripple Effect of GLP1s. Hope it’s as interesting to read as it was to write. ro.co/weight-loss/po…
English
saman rahmanian retweetledi

People with obesity want to lose weight, are motivated to improve their health, and dedicated to sticking with what it takes to do so–but they need better care and support. Read more insights from @Ro’s survey with @ObesityAction: ro.co/weight-loss/ob…
English

An incredibly thoughtful Q&A from @ZReitano on the questions driving the discourse around obesity and GLP-1s today. It's well worth the read to better understand this complex condition and the available treatments based on the data and science.
Z Reitano@ZReitano
1/ Decided to publish “Obesity: An Accusation Audit”. Started as an internal resource for @ro but posting it bc I’ve seen the public discourse talk about very similar subjects concerning weight loss and obesity, without being grounded in research and data ro.co/weight-loss/ac…
English

6/ Our goal is never to either diminish other people’s life choices or to cause anyone harm by viewing our ad, but to start a conversation. We wrote more about the process behind the campaign here. We’re glad the conversation is happening and so are our patients.
medium.com/ro-co/why-were…
English

1/ Our ads were recently slammed for being ‘too evocative’. I think our ads, and the coverage, are starting the exact conversation that we at Ro think is vital to have for patients. For decades, people have viewed obesity differently than other chronic diseases and the reaction to our ads continue to reaffirm this. Here are some sentiments I shared with our team today: nypost.com/2023/04/03/weg…
English

Obesity isn’t a failing of self-control. Our new Body Program campaign spotlights obesity as a chronic condition that is worthy of high-quality care + effective treatment – and tells people that they can feel empowered to seek just that if they want to.
medium.com/ro-co/why-were…
English

Our team is driven by a mission to help our patients achieve their goals. Now Ro is tackling obesity—one of the biggest health challenges facing our patients and society. Learn more: ro.co/weight-loss/
English

There’s a huge gap in obesity care. People are told that their weight is a failing of self-control or discipline. We know this could not be further from the truth. That’s why @ro built the Body Program. cnbc.com/2023/01/20/tre…
English

